The use of antidepressants in the long-term treatment should not improve the impact of fibromyalgia on quality of life

Clinical Practice and Epidemiology in Mental Health

Volumn 9, Issue , 2013, Pages 120-124

  Carta, M G ^a   Ruggiero, V ^b   Sancassiani, F ^a   Cutrano, F ^a   Manca, A R ^a   Peri, M ^b   Fais, A ^b   Cacace, E ^b  

^a University Hospital of Cagliari   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antidepressants; Efficacy; Fibromyalgia; Long Term Treatment; Quality of life

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISABILITY; DRUG EFFICACY; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FOLLOW UP; FUNCTIONING ASSESSMENT SHORT TEST; HAMILTON SCALE; HUMAN; LONG TERM CARE; MOOD DISORDER QUESTIONNAIRE; OBSERVATIONAL STUDY; PSYCHOMETRY; QUALITY OF LIFE; SCREENING TEST; SHORT FORM 12; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT DURATION; TREATMENT RESPONSE; ASSESSMENT OF HUMANS; COMPARATIVE STUDY; DSM-IV; HAMILTON DEPRESSION RATING SCALE; MIDDLE AGED;

EID: 84884272032     PISSN: None     EISSN: 17450179     Source Type: Journal    
DOI: 10.2174/1745017901309010120     Document Type: Article

References (34)

1. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 2388-95. (Pubitemid 39491924)
2. Häuser W, Urrútia G, Tort S, Uçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013; 1: CD010292.
3. Carta MG, Cardia C, Mannu F, et al. The high frequency of manic symptoms in fibromyalgia does influence the choice of treatment? Clin Pract Epidemol Ment Health 2006; 2: 36.
4. Fountoulakis KN, Kasper S, Andreassen O, et al. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 2012; 262 Suppl 1: 1-48.
5. Ei-Mallakh RS, Karippot A. Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series. J Affect Disord 2005; 84(2-3): 267-72. (Pubitemid 40222509)
6. Carta MG, Balestrieri M, Murru A, Hardoy MC. Adjustment Disorder: epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health 2009; 5: 15.
7. Wolfe F, Clauw D J, Fitzcharles M-A, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res 2010; 62 (5): 600-10.
8. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire (FIQ): development and validation. J Rheumatol 1991; 18: 728-33.
9. Sarzi-Puttini P, Atzeni F, Fiorini T, et al. Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 2003; 21(4): 459-64. (Pubitemid 36950314)
10. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I Disorders clinician version (SCID-CV). Washington DC: American Psychiatric Press 1997.
11. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64(1): 53-9. (Pubitemid 36182230)
12. Hardoy MC, Cadeddu M, Murru A, et al. Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders. Clin Pract Epidemol Ment Health 2005; 1: 8.
13. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34(3): 220-33. (Pubitemid 126433231)
14. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health 2007; 3: 5.
15. Moro MF, Colom F, Floris F, et al. Validity and Reliability of the Italian Version of the Functioning Assessment Short Test (FAST) in Bipolar Disorder. Clin Pract Epidemiol Ment Health 2012; 8: 67-73.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
17. Van Houdenhove B, Egle UT. Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together. Psychother Psychosom 2004; 73: 267-75. (Pubitemid 39060995)
18. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005; 71: 483-90. (Pubitemid 40194067)
19. Zimmerman M , Galione JN, Chelminski I, Young D, Dalrymple K. Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder. Psychiatry Res 2011; 185(3): 444-9.
20. Wilke WS, Gota CE, Muzina DJ. Fibromyalgia and bipolar disorder: a potential problem? Bipolar Disord 2010; 12(5): 514-20.
21. Mustafa AF, Almoshmosh N, Al-Robb H, AbuKmeil S. A Case of Possible Duloxetine-Induced Mania, German J Psychiatry 2010. Available at: http://www.gjpsy.uni-goettingen.de
22. Alciati A, Sarzi-Puttini P, Batticciotto A, et al. Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder. Clin Exp Rheumatol 2012; 30(SUPPL.74): S122-8.
23. Van Houdenhove B, Neerinckx E, Onghena P, Lysens R, Vertommen H. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia: An etiological factor or proof of good citizenship? J Psychosom Res 2001; 51(4): 571-6. (Pubitemid 33039741)
24. Carta MG, Angst J. Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemol Ment Health 2005; 1(1): 4.
25. Akiskal HS. The bipolar spectrum: new concepts in classification and diagnosis. In: Grinspoon L, Ed. Psychiatry update: The American Psychiatry Association Annual Review Washington DC: American Psychiatry Press 1983; pp. 271.92.
26. Angst J, Meyer TD, Adolfsson R, et al. Hypomania: a transcultural perspective. World Psychiatry 2010; 9(1): 41-9.
27. Carta MG, Hardoy MC, Cadeddu M, et al. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Mood Disorder Questionnaire (MDQ) in a clinical sample. Clin Pract Epidemol Ment Health 2006; 8: 2.
28. Cerullo MA, Strakowski SM. A systematic review of the evidence for the treatment of acute depression in bipolar I disorder. CNS Spectr 2013; 18: 1-10.
29. Grunze H, Vieta E, Goodwin GM, et al. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the longterm treatment of bipolar disorder. World J Biol Psychiatry 2013; 14(3): 154-219 .
30. American Psychiatric Association. DSM-IV TR. US: APA Washington 2000.
31. Carta MG, Tondo L, Balestrieri M, et al. Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder. BMC Psychiatry 2011; 11: 164.
32. Carta MG, Aguglia E, Bocchetta A, et al. The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy. Clin Pract Epidemiol Ment Health 2010; 6: 94-100
33. Koukopoulos A, Koukopoulos A. Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin North Am 1999; 22 (3): 547-64. (Pubitemid 29463707)
34. Raja M. Delayed loss of efficacy and depressogenic action of antidepressants. J Clin Psychopharmacol 2009; 29(6): 612-4.